Is Osimertinib included in medical insurance?

Osimertinib is a third-generation EGFR tyrosine kinase inhibitor (TKI) that provides a treatment option for many patients with lung cancer.

Is Osimertinib included in the medical insurance?

has been officially included in China's national medical insurance directory.

Chinese patients who meet the indications can enjoy medical insurance reimbursement when purchasing osimertinib in hospital pharmacies. Personal out-of-pocket expenses will be significantly reduced, reducing the economic pressure of long-term treatment.

Patients need to be diagnosed by a specialist and confirm that their tumor type and gene mutation status meet the medical insurance reimbursement conditions (usually including adjuvant therapy, first-line treatment for EGFR mutation-positive NSCLC, and treated T790M-positive metastatic NSCLC) before they can be reimbursed according to the medical insurance policy. In addition to original drugs, there are also a variety of approved generic drugs on the market, providing patients with more choices.

How to use Osimertinib

1. Standard dosage and administration

(1). Recommended dosage: 80 mg (one tablet) each time, once a day.

(2) How to take: It can be taken with food or on an empty stomach. It will not affect absorption. Swallow the tablets whole with a full glass of water; do not crush, chew, or break the tablets.

2. Dose adjustment and special treatment

(1). Missed dose: If you forget to take a dose, you do not need to take it again. You only need to take one tablet as usual at the next scheduled time. Never take a double dose at one time.

(2) Duration of treatment: Treatment should be continued until disease progression or intolerable toxicity occurs. For postoperative adjuvant treatment, the recommended course of treatment is up to 3 years.

(3) Treatment of dysphagia: If the patient is unable to swallow the whole tablet, the tablets can be placed in a container with 60 ml of non-carbonated water and stirred until dispersed into small pieces (not completely dissolved), drink immediately, then rinse the container with water and drink. If administration via nasogastric tube is required, inject the dispersion through the nasogastric tube with a syringe and flush the tube with water.

3. Principle of dose adjustment

When a patient experiences a serious adverse reaction, the doctor will decide whether to suspend the medication, reduce the dose (such as reducing to 40 mg once a day) or permanently discontinue the medication based on the severity of the side effect. All dose adjustments must be made under the guidance of a physician and should not be made by the patient on their own.